PPT-Hepatocellular Carcinoma in the Absence of Cirrhosis

Richa Shukla Faculty mentor Dr Sahil Mittal February 12 2015 Case discussion Reason for presentation Abdominal pain 41F with medical history significant for HLD HTN and DM Presented to ED with 6 months of waxing and waning RUQ pain worse over 34 weeks prior to presentation. Associate Professor of Medicine. Division of . Gastroenterology. /Hepatology. University of Utah Health Sciences Center. Referral for Liver Transplantation Evaluation. Last . Updated: . September . 3. Hilda T Marima- Matarira. Professor of Chemical Pathology. University of Zimbabwe. Objectives. To . evaluate the clinical utility of biochemical . tests. , . ie.. Alpha-Fetoprotein . (AFP) , . Alkaline Phosphatase . Richa Shukla. Faculty mentor: Dr. Sahil Mittal. February 12, 2015. Case discussion. Reason for presentation: Abdominal pain. 41F with medical history significant for HLD, HTN and DM. Presented to ED with 6 months of waxing and waning RUQ pain, worse over 3-4 weeks prior to presentation. risk factors and pathogenesis. Dr Richard Phillips. KNUST/KATH. Introduction. 0.25-1.2 million . cases worldwide per . year. 5. th. most common human cancer. . 80% of burden in developing countries. Kings College Hospital London UK. . 20–50%. . <1.0%. . 2–3%. . 7–8%. . 3–5%. . 2–6% for HBeAg+. . 20–50%. <0.2%. . 8–10% for HBeAg-. HBV-related liver disease progression. Authors. : . Federico Piñero. 1,11,12. , Fernando Rubinstein. 15. , . Sebastián. Marciano. 2. , Nora Fernández. 5. , Jorge Silva. 10. , . Yanina. Zambelo. 8. , Margarita Anders. 4. , . Alina. Zerega. Serum Squamous . Cell Carcinoma Antigen (SCCA) for Prediction of HCC Patients . Presented . By:. Sally Saad Mandour Esawy. Ass. . Lecturer of Clinical Pathology. National Liver Institute, . Menoufia. Curtis Barry, MD. UMASS ECHO. April 21, 2017. Ascites. The Development of Ascites. Revised Underfill. . Peripheral vasodilation occurs as the result of decreased hepatic clearance of vasodilators such as glucagon and NO. ● ● CBC with differential , liver function test ( LFTs ) , c reatinine , electrolytes , PT / INR , lipid profile , hemoglobin A 1 C , alpha - fetoprotein ( AFP ) ● Viral serologies if 4874 Key words (MeSH)Carcinoma hepatocellularMagnetic resonance Liver neoplasms Palabras clave (DeCS)Carcinoma hepatocelularImagen por resonancia Neoplasias hepáticas Magnetic Resonance Imaging of th TLC and THCCC. Hashem B. El-Serag, MD, MPH. Chair and Professor. Department of Medicine. Baylor College of Medicine. Houston, Texas. Translational Liver Cancer (TLC) Consortium . TLC is addressing these challenges in HCC research. . Hepatocellular Carcinoma. Risk factors for HCC. HBV – the most common causative risk factor. Increased risk :. Earlier infection. Higher DNA load (>2000 IU/L). Higher level of quant. . HbsAg. (>10,000 U/L). Prepared by:. Prof. Ammar Al Rikabi. Dr. Sayed Al Esawy. Head of Pathology Department: Dr. Hisham Al Khalidi. Hepatobiliary. system. Integrated practical. 27-12-2017. Hepatobiliary system. Pathology Dept, KSU.